SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-024488
Filing Date
2012-04-27
Accepted
2012-04-27 16:48:17
Documents
1
Period of Report
2012-04-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v310763_3.html 3  
1 OWNERSHIP DOCUMENT v310763_3.xml 3 1504
  Complete submission text file 0001144204-12-024488.txt   3100
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address
SCHOENEBAUM MARK (Reporting) CIK: 0001548537 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32639 | Film No.: 12790461